Diagnostic Products Corporation, founded in 1971, is a leader in the global in vitro diagnostics market. DPC's product offering includes the widely accepted IMMULITE(R) series of immunoassay systems, more than 75 immunoassays and an expanding menu of essential specific allergens and allergy panels that are run just like other immunoassays. DPC also designs and manufactures automated laboratory instrumentation and automation solutions that provide fast, accurate results while enabling our customers to do "more with less" in a leaner laboratory. DPC's combined chemistry and immunoassay menu is one of the largest and most diversified available, covering most laboratory tests requested. In fiscal 2005 (December 31), DPC reported sales of $481 million and income from operations of $96 million.

Makes systems for blood and cell analysis

USAMRMC

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Innovate Calgary is where startups, entrepreneurs, researchers, investors, industry and partners take innovation and ideas to business. It takes an ecosystem to drive the commercialization success of an innovation or discovery, and we are here to give you the help you need to take your startup, discovery or investment to the next stage of growth or market entry. How? It's simple, Just Ask. Innovate Calgary is the technology-transfer and business-incubation centre for the University of Calgary. Working closely with Research Services and the Office of the Vice-President (Research), we work to help bridge the gap between discovery and innovation.

AltaRex Medical Corp., a subsidiary of Endo International Plc, is a Canadian company located in Edmonton, AB, that develops and research foreign antibodies for cancer and life-threatening disease treatment. It was acquired by ViRexx Medical Corp., now a subsidiary of Endo International Plc on December 13, 2004 for $22.66 million.

Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment systems for cancer diagnosis and treatment in South Korea. It offers Smart Biopsy, an automated CTC enrichment system from blood sample; and cell isolators, IF stainers, cell image analyzers, time laps analyzers, isolation kits, and culture kits. The company was founded in 2010 and is headquartered in Seoul, South Korea.

Provides fully integrated contract manufacturing services to medical device manufacturers worldwide in the cardiovascular, endoscopy and orthopedic markets